CF-TAT-substrate

General Information


DRACP ID  DRACP05634

Peptide Name   CF-TAT-substrate

Sequence  YGRKKRRQRRREILSRXPAYRKIL

Sequence Length  24

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  5(6)-Carboxyfluorescein

C-terminal Modification  Free

Other Modification  X=ATP-binding site inhibitors

Chiral  L



Physicochemical Information


Formula  C131H229N51O29

Absent amino acids  CDFHMNTVW

Common amino acids  R

Mass  350298

Pl  12.51

Basic residues  11

Acidic residues  1

Hydrophobic residues  5

Net charge  10

Boman Index  -12961

Hydrophobicity  -173.75

Aliphatic Index  69.17

Half Life 
  /

Extinction Coefficient cystines  2980

Absorbance 280nm  129.57

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23621550

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2543

DRACP is developed by Dr.Zheng's team.